No Data
US Stock MarketDetailed Quotes
ILMN Illumina
Watchlist
109.790
+7.840+7.69% Close 12/01 16:00 ET
109.7900.0000.00%
Pre 04:00 ET
110.580High100.185Low4.14MVolume
101.430Open101.950Pre Close445.74MTurnover2.61%Turnover RatioLossP/E (TTM)17.43BMarket Cap238.55052wk HighLossP/E (Static)158.80MShares89.00052wk Low2.96P/B17.40BFloat Cap555.770Historical High--Dividend TTM158.44MShs Float0.855Historical Low--Div YieldTTM10.20%Amplitude107.788Avg Price1Lot Size
Pre-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
About Illumina Company
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.
Revenue Breakdown
Business
Currency:USD
2023/01/01
Stock NameRevenueRatio
Core Illumina4.55B99.32%
GRAIL55M1.20%
Eliminations-24M-0.52%
News
Video: Merging Discovery With Clinical Care at Ontario Institute for Cancer Research
Inside the Canadian icon pushing the boundaries of precision oncologyNORTHAMPTON, MA / ACCESSWIRE / November 30, 2023 / IlluminaOriginally published on Illumina News CenterIn the middle of downtown To
Illumina, Inc. (ILMN) Piper Sandler 35th Annual Healthcare Conference (Transcript)
Illumina, Inc. (ILMN) Piper Sandler 35th Annual Healthcare Conference (Transcript)
Is Now An Opportune Moment To Examine Illumina, Inc. (NASDAQ:ILMN)?
Today we're going to take a look at the well-established Illumina, Inc. (NASDAQ:ILMN). The company's stock saw significant share price movement during recent months on the NASDAQGS, rising to high
Comments
Given its undervaluation and optimistic earnings outlook, this might provide a investment opportunity to buy low for Illumina's stock. However, other factors such as the management team and capital structure should also be considered for a well-informed decision.
Read more
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--